Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Arbutus Biopharma Corporation logo

Arbutus Biopharma Corporation

Sector: Healthcare   

Industry: Biotechnology

2.60
 
USD
  
0.11
  
(4.42%)
Optionable: Yes  Market Cap: 447 M  90-day average vol: 961,392

Previous close: 2.49  Open: 2.49  Bid: 2.47  Ask: 2.6
52 week range    
1.69   
   3.15
Peers   
NWBO / 
NYMX / 
OHCS / 
Last updated: Thursday 28th March 2024
52
MarketXLS Rank
60
Value
61
Technical
36
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ABUS Cash Flow

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
(Increase) Decrease in other current assets693000.0128000.0
(Increase) Decrease in other current liabilities13 M-13 M-1 M3 M-1 M-744000.0-375000.0-374000.022 M-11 M
(Increase) Decrease in payables6 M-2 M26000.0736000.0-870000.0-3 M2 M2 M5 M-6 M
(Increase) Decrease in receivables-2 M789000.0688000.0-176000.0-1 M227000.0-108000.0413000.0-453000.0-424000.0
Acquisitions324000.0-2 M
AssetImpairmentCharge39 M391 M41 M15 M66 M
CapitalExpenditureReported1 M2 M4 M7 M1 M589000.0229000.0809000.0512000.01 M
Cash at beginning of period69 M72 M167 M23 M54 M37 M32 M52 M109 M31 M
Cash at end of period72 M189 M63 M54 M76 M32 M52 M109 M31 M26 M
Cash flow-9 M-33 M-20 M-50 M-21 M-71 M-52 M-69 M-38 M-86 M
CashFlowFromContinuingInvestingActivities-43 M8 M-98 M29 M-11 M28 M-14 M-11 M-73 M51 M
ChangeInAccountPayable6 M-2 M26000.0736000.0-1 M-3 M2 M2 M5 M-6 M
ChangeInPayablesAndAccruedExpense6 M-2 M26000.0736000.0-870000.0-3 M2 M2 M5 M-6 M
ChangeInPrepaidAssets-773000.0159000.0-115000.0-833000.0-648000.02 M-752000.0-1 M2 M-943000.0
ChangeInWorkingCapital16 M-15 M-467000.03 M-4 M-2 M431000.0925000.029 M-18 M
ChangesInAccountReceivables-2 M628000.0735000.0-129000.0-1 M227000.0-108000.0413000.0-453000.0-424000.0
Current deferred income taxes-16 M-105 M-24 M-4 M-13 M
Deferred income taxes-16 M-105 M-24 M-4 M-13 M
Depreciation529000.0589000.01 M2 M2 M2 M2 M2 M1 M1 M
Depreciation unreconciled529000.0589000.01 M2 M2 M2 M2 M3 M1 M-796000.0
DepreciationAndAmortization529000.0589000.01 M2 M2 M2 M2 M3 M1 M-796000.0
EarningsLossesFromEquityInvestments5 M
Effect of exchange rate changes-2 M-2 M1 M2 M-1 M68000.056000.05000.0-22000.025000.0
FinancingCashFlow61 M144 M13 M49 M56 M37 M87 M137 M32 M31 M
Free cash flow-13 M-36 M-24 M-57 M-23 M-72 M-52 M-70 M-36 M-87 M
GainLossOnInvestmentSecurities10 M-3 M-530000.022000.0
GainLossOnSaleOfPPE-80000.0174000.0-3000.0-26000.020000.0-20000.0
InterestPaidSupplementalData104000.0
Issuance of capital stock56 M142 M19 M86 M461000.0395000.0535000.0
Issuance of debt-12 M
IssuanceOfCapitalStock56 M142 M19 M86 M461000.0395000.0535000.0
IssuanceOfDebt12 M-12 M
Net cash from financing activities61 M144 M13 M49 M56 M37 M87 M137 M32 M31 M
Net cash from investing activities-43 M8 M-98 M29 M-11 M28 M-14 M-11 M-75 M51 M
Net cash from operating activities-12 M-33 M-20 M-50 M-21 M-71 M-52 M-69 M-35 M-86 M
Net change in cash & cash equivalents2 M117 M-104 M31 M22 M-5 M20 M57 M-78 M-5 M
Net income from continuing operations-39 M-61 M-384 M-84 M-57 M-154 M-64 M-76 M-69 M-73 M
NetBusinessPurchaseAndSale324000.0-2 M2 M2 M69000.0
NetCommonStockIssuance56 M142 M19 M86 M461000.0395000.0535000.0
NetForeignCurrencyExchangeGainLoss-4 M-22 M-1 M-2 M1 M-68000.0-56000.0-5000.0
NetInvestmentPropertiesPurchaseAndSale-42 M10 M-94 M36 M-10 M29 M-12 M-12 M-74 M52 M
NetInvestmentPurchaseAndSale-42 M10 M-94 M36 M-10 M29 M-12 M-12 M-74 M52 M
NetIssuancePaymentsOfDebt12 M-12 M
NetLongTermDebtIssuance12 M
NetPPEPurchaseAndSale-976000.0-2 M-4 M-7 M-1 M-578000.0-229000.0-809000.0-512000.0-988000.0
NetPreferredStockIssuance49 M66 M
Operating (gains) losses6 M-25 M-1 M-2 M977000.0-48000.0-56000.0-5000.0-20000.0
Other financing charges net19 M135 M31 M30 M
Other investing changes net770000.02 M1 M-7 M-173000.0473000.02 M
Other non-cash items7 M83 M470 M56 M41 M96 M9 M3 M1 M6 M
PreferredStockIssuance49 M66 M
ProceedsFromIssuanceOfWarrants2 M42000.0445000.0353000.0
ProceedsFromStockOptionExercised3 M2 M192000.0100000.01 M307000.0449000.02 M122000.0260000.0
Purchase of Float term investments-42 M10 M-83 M35 M-122 M-59 M-86 M-82 M-130 M-81 M
Purchase of property plant & equipment-976000.0-2 M-4 M-7 M-1 M-578000.0-229000.0-809000.0-512000.0-988000.0
Purchase of short term investments12 M
PurchaseOfInvestment-42 M10 M-95 M35 M-122 M-59 M-86 M-82 M-130 M-81 M
PurchaseOfLongTermInvestments-13 M
PurchaseOfPPE-1 M-2 M-4 M-7 M-1 M-589000.0-229000.0-809000.0-512000.0-1 M
RepaymentOfDebt-12 M
Revenue per share-275000.0210000.0999000.0-54000.0-2 M
Sale of short term investments119 M88 M73 M70 M56 M132 M
SaleOfBusiness473000.02 M2 M69000.0
SaleOfInvestment119 M88 M73 M70 M56 M132 M
SaleOfPPE80000.025000.03000.025000.011000.020000.0
ShortTermDebtPayments-12 M
StockBasedCompensation7 M44 M78 M15 M6 M7 M6 M6 M7 M9 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University